Vincenzo Emanuele Chiurì
Ospedale Sacro Cuore Don Calabria(IT)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Cancer Treatment and Pharmacology, Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial(2018)406 cited
- → Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone(2016)198 cited
- → Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study(2019)52 cited
- → Real-world Cabazitaxel Safety: The Italian Early-Access Program in Metastatic Castration-Resistant Prostate Cancer(2013)49 cited
- → Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors(2024)31 cited
- → Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial(2022)30 cited
- → Association among metabolic syndrome, inflammation, and survival in prostate cancer(2018)29 cited
- → Prognosis of screen-detected breast cancers: results of a population based study(2006)29 cited
- → Standard vs Adapted Sunitinib Regimen in Elderly Patients With Metastatic Renal Cell Cancer: Results From a Large Retrospective Analysis(2013)26 cited
- → Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer(2014)26 cited